Valentina Fermi
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Automated and personalized glioblastoma tumor organoid drug screening platform exposes sensitivity to proteasome and HDAC inhibitors.
Journal: NPJ precision oncology
Published: August 20, 2025
Individualized patient tumor organoids faithfully preserve human brain tumor ecosystems and predict patient response to therapy.
Journal: Cell stem cell
Published: December 22, 2023
Effective Reprogramming of Patient-Derived M2-Polarized Glioblastoma-Associated Microglia/Macrophages by Treatment with GW2580.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 24, 2023
Luminescent Pyrrole-Based Phosphaphenalene Gold Complexes: Versatile Anticancer Tools with Wide Applicability.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: May 26, 2022
Luminescent Pyrrole-Based Phosphaphenalene Gold Complexes: Versatile Anticancer Tools with Wide Applicability.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: December 23, 2021
Correction: Gold(I) complexes based on six-membered phosphorus heterocycles as bio-active molecules against brain cancer.
Journal: Chemical communications (Cambridge, England)
Published: November 20, 2020
Gold(i) complexes based on six-membered phosphorus heterocycles as bio-active molecules against brain cancer.
Journal: Chemical communications (Cambridge, England)
Published: October 30, 2020
Single-nucleus chromatin accessibility reveals intratumoral epigenetic heterogeneity in IDH1 mutant gliomas.
Journal: Acta neuropathologica communications
Published: November 13, 2019
Identification of T cell target antigens in glioblastoma stem-like cells using an integrated proteomics-based approach in patient specimens.
Journal: Acta neuropathologica
Published: December 28, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026